Ticker Details
Axogen, Inc. Common Stock AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries.
IPO Date:	January 1, 1987
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$1.77B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 2.45%
Avg Daily Range (30 D):	$0.67 | 2.02%
Avg Daily Range (90 D):	$0.61 | 2.20%

Institutional Daily Volume
Avg Daily Volume:	.28M
Avg Daily Volume (30 D):	.89M
Avg Daily Volume (90 D):	.79M

Trade Size
Avg Trade Size (Sh.):	90
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	1,417
Avg Institutional Trade:	$1.41M
Avg Institutional Trade (30 D):	$2.06M
Avg Institutional Trade (90 D):	$2.01M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.51M
Avg Closing Trade (30 D):	$3.34M
Avg Closing Trade (90 D):	$2.8M
Avg Closing Volume:	82.44K

News

Feb 17, 2026 @ 12:00 PM Axogen, Inc. to Participate in Multiple Upcoming I... Source: Na

Feb 10, 2026 @ 12:00 PM Axogen, Inc. to Report Fourth Quarter and Full Yea... Source: Na

Jan 22, 2026 @ 4:18 AM Axogen Announces Pricing of Upsized $124 Million P... Source: Na

Jan 12, 2026 @ 12:00 PM Axogen, Inc. Reports Preliminary Unaudited Revenue... Source: Na

Dec 4, 2025 @ 1:01 AM Axogen Announces FDA Approval of Biologics License... Source: Axogen, Inc.

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$.02	$.01	$-.08
Diluted EPS	$.01	$.01	$-.08
Revenue	$60.08M	$56.66M	$48.56M
Gross Profit	$45.99M	$42.02M	$34.93M
Net Income / Loss	$.71M	$.58M	$-3.83M
Operating Income / Loss	$1.91M	$1.67M	$-1.66M
Cost of Revenue	$14.09M	$14.64M	$13.63M
Net Cash Flow	$1.87M	$1.94M	$-9.46M
PE Ratio	3,169.88